News | Page 2 of 7 | 53Biologics

May 29, 2024 Patricia De La Madrid Comments: 0

The President of the Junta de Castilla y León visits 53Biologics and Highlights its Success

The President of the Junta de Castilla y León has emphasized the capacity of this sector to encourage competitiveness in the community and, from here, to be part of the change. The President of the Junta de Castilla y León, Alfonso Fernández Mañueco, has visited 53Biologics in the Technology Park of Boecillo (Valladolid) where this company has been located since its creation in 2017. A complex that already reaches more than 4,000 square meters and from which it strongly supports all those co...

May 10, 2024 Patricia De La Madrid Comments: 0

Flexible, agile and customer-focused. This is 53Biologics

Given the intricate and unpredictable nature of pharmaceutical development, being agile, flexible and customer-focused have become indispensable elements for drug developers seeking partnerships with CDMOs. In this article, we delve into the distinctive value proposition of 53Biologics’ services and how these solutions are tailored to address the specific requirements of its clients. “Our clients are the innovators who develop treatments that are currently not available. We are committ...

April 19, 2024 Patricia De La Madrid Comments: 0

Expand Your Horizons: Must-Read Books for Scientists

In the ever-evolving landscape of scientific discovery, staying informed and inspired is crucial for every researcher and scientist. Whether you’re a seasoned professional or an aspiring student, books offer invaluable insights and perspectives to fuel your passion for science. Here’s a curated list of must-read books that promise to broaden your horizons and ignite your curiosity: 1. “The Emperor of All Maladies: A Biography of Cancer” by Siddhartha Mukherjee Dive into t...

March 19, 2024 Patricia De La Madrid Comments: 0

Understanding The World of Biotherapeutic Proteins

Biotherapeutic proteins have great clinical success and are now highly recognized for their great potential against numerous diseases. The term “protein” was proposed in 1838 by Jöns Jakob Berzelius and etymologically the word derives from the Greek proteios (fundamental, principal, in time, place, order or importance). Although it is debatable which molecules are the most important for life, currently therapeutic proteins are the most important biologics in terms of their clinical...

November 29, 2023 Patricia De La Madrid Comments: 0

Unwrap the Unexpected: Gift Ideas for Your Scientific Friends

A Biopharma CDMO’s Guide to Thoughtful Presents from 53Biologics The holiday season is upon us, and what better way to celebrate than by showing appreciation for your scientific comrades? At 53Biologics, a Biopharma CDMO dedicated to Clinical Development and GMP Manufacturing, we’ve curated a list of unique gifts sure to delight the brilliant minds in your lab. Plus, you can conveniently find these items on Amazon, making your holiday shopping a breeze. 1. Molecular Gastronomy Kit: S...

November 29, 2023 Patricia De La Madrid Comments: 0

Gratitude in Growth: A Thanksgiving Celebration with 53Biologics

As Thanksgiving approaches, the team at 53Biologics takes a moment to express heartfelt thanks for the strides we’ve collectively achieved in the realm of biopharmaceuticals. Our specialized Process Development line and three dedicated GMP Manufacturing lines, including cell banking and production capacities up to 2000L, have played a crucial role in this journey. A Year of Collaborative Success This past year has been marked by collaborative breakthroughs, where our expertise in Process D...

June 29, 2023 Patricia De La Madrid Comments: 0

Innovating DNAse Enzymes

In our latest project, we’re diving into the world of mRNA-based vaccines, aiming to optimize the production process for DNAse enzymes. This endeavor holds immense importance as it paves the way for the development of more robust and reproducible mRNA synthesis methods, ultimately enhancing the efficiency and scalability of vaccine production. By focusing on industrializing and optimizing this critical aspect of mRNA synthesis, we’re contributing to the advancement of biopharmaceutic...

April 28, 2023 Patricia De La Madrid Comments: 0

Introducing 53Biologics’ New 2000L GMP Production Line for Biologics

53Biologics, a leading CDMO specializing in biologics production and cGMP manufacturing for biological products, is pleased to announce the opening of a new GMP production line for microbial. The new production line boasts a 2000L reactor, making it one of the largest of its kind in the world. This new addition to 53Biologics’s manufacturing facility allow them to meet the growing demand for microbial-based products and serve more clients across the globe. In addition to the 2000L reactor,...

April 4, 2023 Patricia De La Madrid Comments: 0

Happy Easter from the 53Biologics team!

On behalf of the entire team at 53Biologics, we would like to wish all our clients and their loved ones a happy and joyous Easter holiday. May this special occasion bring you lots of happiness and laughter. As a biopharma CDMO dedicated to improving the lives of people around the world, we understand the importance of taking time to celebrate and appreciate the things that matter most in life. We hope that this Easter holiday provides you with a well-deserved break and an opportunity to recharge...

March 28, 2023 Patricia De La Madrid Comments: 0

The role of pDNA in biotech industry

When plasmid DNA was discovered, its function was not even known. Today its importance goes beyond microbial evolution, as it plays a fundamental role in the production of vaccines, gene therapies and cell therapies. What is plasmid DNA? A plasmid is a very special small genetic element. It consists of a circular double-stranded DNA present in many bacterial species capable of self-replicating independently of chromosomal DNA. This capacity already gives it the category of “special&...